TLR9 and neutropenia: When CpG, an immunostimulatory TLR9 agonist, was injected into human volunteers[66], [67] or injected with a malaria vaccine[68], it induced a transient neutropenia and injection site reactions that were linked to stimulation of the innate immune system and associated white blood cell sequestration[68].